These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 9829840)
21. Mitomycin C, cisplatin, and 5-fluorouracil for advanced and/or recurrent head and neck squamous cell carcinomas. Iop A; Cartei G; Vigevani E; Clocchiatti L; Mansutti M; Sibau AM Am J Clin Oncol; 1997 Oct; 20(5):515-8. PubMed ID: 9345340 [TBL] [Abstract][Full Text] [Related]
22. Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer. Vokes EE; Haraf DJ; Mick R; McEvilly JM; Weichselbaum RR J Clin Oncol; 1994 Nov; 12(11):2351-9. PubMed ID: 7525886 [TBL] [Abstract][Full Text] [Related]
23. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up. Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256 [TBL] [Abstract][Full Text] [Related]
24. Modified combination chemotherapy of cisplatin and 5-fluorouracil in squamous cell carcinomas of the head and neck. Furukawa S; Tsukuda M; Mochimatsu I; Kokatsu T; Satoh H; Sakumoto M Auris Nasus Larynx; 1994; 21(3):181-5. PubMed ID: 7872895 [TBL] [Abstract][Full Text] [Related]
25. First safety and response results of a randomized phase III study with liposomal platin in the treatment of advanced squamous cell carcinoma of the head and neck (SCCHN). Jehn CF; Boulikas T; Kourvetaris A; Kofla G; Possinger K; Lüftner D Anticancer Res; 2008; 28(6B):3961-4. PubMed ID: 19192656 [TBL] [Abstract][Full Text] [Related]
26. Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial. Keil F; Hartl M; Altorjai G; Berghold A; Riedl R; Pecherstorfer M; Mayrbäurl B; De Vries A; Schuster J; Hackl J; Füreder T; Melchardt T; Burian M; Greil R Eur J Cancer; 2021 Jul; 151():201-210. PubMed ID: 34022697 [TBL] [Abstract][Full Text] [Related]
27. Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer. Vokes EE; Schilsky RL; Weichselbaum RR; Guaspari A; Guarnieri CM; Whaling SM; Panje WR Cancer; 1989 Mar; 63(6 Suppl):1048-53. PubMed ID: 2783881 [TBL] [Abstract][Full Text] [Related]
28. Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study. Ghi MG; Paccagnella A; D'Amanzo P; Mione CA; Fasan S; Paro S; Mastromauro C; Carnuccio R; Turcato G; Gatti C; Pallini A; Nascimben O; Biason R; Oniga F; Medici M; Rossi F; Fila G Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):481-7. PubMed ID: 15145166 [TBL] [Abstract][Full Text] [Related]
29. A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck. Forastiere AA; Natale RB; Takasugi BJ; Goren MP; Vogel WC; Kudla-Hatch V J Clin Oncol; 1987 Feb; 5(2):190-6. PubMed ID: 3543242 [TBL] [Abstract][Full Text] [Related]
30. Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC). Rivera F; Vega-Villegas ME; López-Brea M; Isla D; Mayorga M; Galdós P; Rubio A; Del Valle A; García-Reija F; García-Montesinos B; Rodríguez-Iglesias J; Mayordomo J; Rama J; Saiz-Bustillo R; Sanz-Ortiz J Cancer Chemother Pharmacol; 2008 Jul; 62(2):253-61. PubMed ID: 17901953 [TBL] [Abstract][Full Text] [Related]
31. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. Jacobs C; Lyman G; Velez-García E; Sridhar KS; Knight W; Hochster H; Goodnough LT; Mortimer JE; Einhorn LH; Schacter L J Clin Oncol; 1992 Feb; 10(2):257-63. PubMed ID: 1732427 [TBL] [Abstract][Full Text] [Related]
32. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007. Worden FP; Moon J; Samlowski W; Clark JI; Dakhil SR; Williamson S; Urba SG; Ensley J; Hussain MH; Cancer; 2006 Jul; 107(2):319-27. PubMed ID: 16779801 [TBL] [Abstract][Full Text] [Related]
33. Continuous infusion of 5-FU with split-dose cisplatin: an effective treatment for advanced squamous-cell carcinoma of the head and neck. Luo Z; Chang J; Guo Y; Yu H; Lu F; Wu X; Li J Clin Invest Med; 2011 Feb; 34(1):E8-13. PubMed ID: 21291636 [TBL] [Abstract][Full Text] [Related]
34. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. Taylor SG; Murthy AK; Vannetzel JM; Colin P; Dray M; Caldarelli DD; Shott S; Vokes E; Showel JL; Hutchinson JC J Clin Oncol; 1994 Feb; 12(2):385-95. PubMed ID: 8113846 [TBL] [Abstract][Full Text] [Related]
35. Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility study. Schrijvers D; Van Herpen C; Kerger J; Joosens E; Van Laer C; Awada A; Van den Weyngaert D; Nguyen H; Le Bouder C; Castelijns JA; Kaanders J; De Mulder P; Vermorken JB Ann Oncol; 2004 Apr; 15(4):638-45. PubMed ID: 15033673 [TBL] [Abstract][Full Text] [Related]
36. Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase I-II trial of the Southern Italy Cooperative Oncology Group (SICOG). Caponigro F; Comella P; Rivellini F; Avallone A; Budillon A; Di Gennaro E; Mozzillo N; Ionna F; De Rosa V; Manzione L; Comella G Ann Oncol; 2000 May; 11(5):575-80. PubMed ID: 10907951 [TBL] [Abstract][Full Text] [Related]
37. A phase I study of cabazitaxel in combination with platinum and 5-fluorouracil (PF) in locally advanced squamous cell carcinoma of head and neck (LA-SCCHN). Camille N; Rozehnal J; Roy E; Uczkowski D; Olson A; Genden E; Teng M; Bakst R; Gupta V; Posner M; Misiukiewicz K Oral Oncol; 2017 Aug; 71():99-104. PubMed ID: 28688700 [TBL] [Abstract][Full Text] [Related]
38. A Phase 2 Open Label, Single-Arm Trial to Evaluate the Combination of Cetuximab Plus Taxotere, Cisplatin, and 5-Flurouracil as an Induction Regimen in Patients With Unresectable Squamous Cell Carcinoma of the Head and Neck. Mesía R; Vázquez S; Grau JJ; García-Sáenz JA; Lozano A; García C; Carles J; Irigoyen A; Mañós M; García-Paredes B; del Barco E; Taberna M; Escobar Y; Cruz JJ; Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):289-96. PubMed ID: 26675064 [TBL] [Abstract][Full Text] [Related]
39. cis-platinum and 5-fluorouracil as initial therapy in advanced epidermoid cancers of the head and neck. Weaver A; Fleming S; Vandenberg H; Drelichman A; Jacobs J; Kinzie J; Loh JJ; Al-Sarraf M Head Neck Surg; 1982; 4(5):370-3. PubMed ID: 7201459 [TBL] [Abstract][Full Text] [Related]
40. Phase II study of cisplatin and continuous-infusion 5-fluorouracil and bleomycin for recurrent and metastatic head and neck squamous-cell carcinoma. Tellez-Bernal E; Belehradek M; Recondo G; Cvitkovic E; Leridant AM; Vericel R; Armand JP Am J Clin Oncol; 1990 Oct; 13(5):452-4. PubMed ID: 1699403 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]